Published in J Diabetes Investig on March 14, 2016
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med (2004) 17.91
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut (2009) 6.50
The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol (2011) 5.55
Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab (2013) 4.88
Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med (2013) 4.15
FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature (2014) 3.34
Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) (2009) 3.15
Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest (2011) 2.93
Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology (2009) 2.93
Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg (2005) 2.59
Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab (2004) 2.21
Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat. Gastroenterology (2010) 1.96
Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes. Diabetes (2013) 1.66
Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care (2011) 1.55
Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities. Am J Physiol Gastrointest Liver Physiol (2010) 1.54
Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency. Mol Metab (2013) 1.33
Ileal interposition improves glucose tolerance in low dose streptozotocin-treated diabetic and euglycemic rats. Obes Surg (2008) 1.30
Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg (2008) 1.25
Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol (2013) 1.21
GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. Am J Physiol Regul Integr Comp Physiol (2014) 1.16
Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1. Am J Physiol Endocrinol Metab (2011) 1.12
Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Annu Rev Physiol (2013) 1.10
Ileal interposition improves glucose tolerance and insulin sensitivity in the obese Zucker rat. Am J Physiol Gastrointest Liver Physiol (2010) 1.07
Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery. Diabetes Care (2013) 1.05
Glucagon-like peptide-1: glucose homeostasis and beyond. Annu Rev Physiol (2013) 1.03
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. Diabetes (2013) 0.97
A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgery. Diabetes Metab J (2014) 0.94
K-cells and glucose-dependent insulinotropic polypeptide in health and disease. Vitam Horm (2010) 0.93
Bile-acid-mediated decrease in endoplasmic reticulum stress: a potential contributor to the metabolic benefits of ileal interposition surgery in UCD-T2DM rats. Dis Model Mech (2012) 0.93
Role of fibroblast growth factor 19 in the control of glucose homeostasis. Curr Opin Clin Nutr Metab Care (2012) 0.90
Endotoxemia, nutrition, and cardiometabolic disorders. Acta Diabetol (2014) 0.89
GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects. Ann Surg (2013) 0.88
Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes. Diabetologia (2015) 0.85
Effects of ileal interposition on glucose metabolism in obese rats with diabetes. Surgery (2012) 0.84
Ileal transposition surgery produces ileal length-dependent changes in food intake, body weight, gut hormones and glucose metabolism in rats. Int J Obes (Lond) (2013) 0.83
Effects of sleeve gastrectomy and ileal transposition, alone and in combination, on food intake, body weight, gut hormones, and glucose metabolism in rats. Am J Physiol Endocrinol Metab (2013) 0.82
Morphological, kinetic, membrane biochemical and genetic aspects of intestinal enteroplasticity. World J Gastroenterol (2009) 0.82
Ileal interposition surgery-induced improvement of hyperglycemia and insulin resistance in Goto-Kakizaki rats by upregulation of TCF7L2 expression. Exp Ther Med (2013) 0.81
The role of the gut hormone GLP-1 in the metabolic improvements caused by ileal transposition. J Surg Res (2011) 0.81
Long segment ileal transposition leads to early amelioration of glucose control in the diabetic obese Zucker rat. Wideochir Inne Tech Maloinwazyjne (2013) 0.81
Ileal Transposition Decreases Plasma Lipopolysaccharide Levels in Association with Increased L Cell Secretion in Non-obese Non-diabetic Rats. Obes Surg (2016) 0.81
Systematic ileal transposition in Zucker rats shows advantage for long segment distal transposition. Surgery (2013) 0.78
Intestinal adaptation and Reg gene expression induced by antidiabetic duodenal-jejunal bypass surgery in Zucker fatty rats. Am J Physiol Gastrointest Liver Physiol (2013) 0.77
Peptide YY induces intestinal proliferation in peptide YY knockout mice with total enteral nutrition after massive small bowel resection. J Pediatr Gastroenterol Nutr (2009) 0.77
Ileal interposition reduces blood glucose levels and decreases insulin resistance in a type 2 diabetes mellitus animal model by up-regulating glucagon-like peptide-1 and its receptor. Int J Clin Exp Pathol (2014) 0.77